Autism spectrum issues. https://www.who.int/news-room/fact-sheets/detail/autism-spectrum-disorders#:~:text=Epidemiology,figures%20that%20are%20substantially%20higher., 2021.
Data & Statistics on Autism Spectrum Disorder. https://www.cdc.gov/ncbddd/autism/data.html, 2021.
Autism Spectrum Disorder (ASD). https://www.nimh.nih.gov/health/statistics/autism-spectrum-disorder-asd, 2022.
Casanova MF, Frye RE, Gillberg C, Casanova EL. Editorial: comorbidity and autism spectrum dysfunction. Front Psychiatry. 2020;11:617395.
Pugsley Ok, Scherer SW, Bellgrove MA, Hawi Z. Environmental exposures related to elevated danger for autism spectrum dysfunction might increase the burden of deleterious de novo mutations amongst probands. Mol Psychiatry. 2022;27:710–30.
Grove J, Ripke S, Als TD, Mattheisen M, Walters RK, Won H, et al. Identification of frequent genetic danger variants for autism spectrum dysfunction. Nat Genet. 2019;51:431–44.
Eyring KW, Geschwind DH. Three a long time of ASD genetics: building a basis for neurobiological understanding and remedy. Hum Mol Genet. 2021;30:R236–44.
Geschwind DH. Autism: many genes, frequent pathways? Cell. 2008;135:391–5.
Gao R, Penzes P. Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum issues. Curr Mol Med. 2015;15:146–67.
Pan Y-H, Wu N, Yuan X-B. Toward a greater understanding of neuronal migration deficits in autism spectrum issues. Front Cell Dev Biol. 2019;7:205–5.
Zhang H. Synaptic dysregulation in autism spectrum issues. J Neurosci Res. 2020;98:2111–4.
Dajani DR, Uddin LQ. Local mind connectivity throughout improvement in autism spectrum dysfunction: a cross-sectional investigation. Autism Res. 2016;9:43–54.
Kumar S, Reynolds Ok, Ji Y, Gu R, Rai S, Zhou CJ. Impaired neurodevelopmental pathways in autism spectrum dysfunction: a evaluate of signaling mechanisms and crosstalk. J Neurodevelop Disord. 2019;11:10.
Lin Y-C, Frei JA, Kilander MBC, Shen W, Blatt GJ. A subset of autism-associated genes regulate the structural stability of neurons. Front Cell Neurosci. 2016;10:263.
Hashem S, Nisar S, Bhat AA, Yadav SK, Azeem MW, Bagga P, et al. Genetics of structural and practical mind modifications in autism spectrum dysfunction. Transl Psychiatry. 2020;10:229–9.
Bigos KL, Hariri AR. Neuroimaging: applied sciences on the interface of genes, mind, and habits. Neuroimaging Clin N. Am. 2007;17:459–viii.
Klein M, van Donkelaar M, Verhoef E, Franke B. Imaging genetics in neurodevelopmental psychopathology. Am J Med Genet B Neuropsychiatr Genet. 2017;174:485–537.
Duverger O, Morasso MI. Role of homeobox genes within the patterning, specification, and differentiation of ectodermal appendages in mammals. J Cell Physiol. 2008;216:337–46.
Rossel M, Capecchi MR. Mice mutant for each Hoxa1 and Hoxb1 present intensive transforming of the hindbrain and defects in craniofacial improvement. Development. 1999;126:5027–40.
Conciatori M, Stodgell CJ, Hyman SL, O’Bara M, Militerni R, Bravaccio C, et al. Association between the HOXA1 A218G polymorphism and elevated head circumference in sufferers with autism. Biol Psychiatry. 2004;55:413–9.
Muscarella LA, Guarnieri V, Sacco R, Militerni R, Bravaccio C, Trillo S, et al. HOXA1 gene variants affect head progress charges in people. Am J Med Genet B Neuropsychiatr Genet. 2007;144b:388–90.
Muscarella LA, Guarnieri V, Sacco R, Curatolo P, Manzi B, Alessandrelli R, et al. Candidate gene examine of HOXB1 in autism spectrum dysfunction. Mol Autism. 2010;1:9.
Cummings Ok, Watkins A, Jones C, Dias R, Welham A. Behavioural and psychological options of PTEN mutations: a scientific evaluate of the literature and meta-analysis of the prevalence of autism spectrum dysfunction traits. J Neurodevelop Disord. 2022;14:1.
Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z, Brown M, Takahashi TN, et al. Subset of people with autism spectrum issues and excessive macrocephaly related to germline PTEN tumour suppressor gene mutations. J Med Genet. 2005;42:318–21.
Buxbaum JD, Cai G, Chaste P, Nygren G, Goldsmith J, Reichert J, et al. Mutation screening of the PTEN gene in sufferers with autism spectrum issues and macrocephaly. Am J Med Genet B Neuropsychiatr Genet. 2007;144b:484–91.
Frewer V, Gilchrist CP, Collins SE, Williams Ok, Seal ML, Leventer RJ, et al. A scientific evaluate of mind MRI findings in monogenic issues strongly related to autism spectrum dysfunction. J Child Psychol Psychiatry. 2021;62:1339–52.
Tan GCY, Doke TF, Ashburner J, Wood NW, Frackowiak RSJ. Normal variation in fronto-occipital circuitry and cerebellar construction with an autism-associated polymorphism of CNTNAP2. Neuroimage. 2010;53:1030–42.
Agarwala S, Ramachandra NB. Role of CNTNAP2 in autism manifestation outlines the regulation of signaling between neurons on the synapse. Egypt J Med Hum Genet. 2021;22:22.
Chien Y-L, Chen Y-C, Gau SS-F. Altered cingulate buildings and the associations with social consciousness deficits and CNTNAP2 gene in autism spectrum dysfunction. NeuroImage: Clin. 2021;31:102729.
Peng Y, Huentelman M, Smith C, Qiu S. MET receptor tyrosine kinase as an autism genetic danger issue. Int Rev Neurobiol. 2013;113:135–65.
Campbell DB, Sutcliffe JS, Ebert PJ, Militerni R, Bravaccio C, Trillo S, et al. A genetic variant that disrupts MET transcription is related to autism. Proc Natl Acad Sci USA. 2006;103:16834–9.
Rudie JD, Hernandez LM, Brown JA, Beck-Pancer D, Colich NL, Gorrindo P, et al. Autism-associated promoter variant in MET impacts practical and structural mind networks. Neuron. 2012;75:904–15.
Xu Q, Liu Y-Y, Wang X, Tan G-H, Li H-P, Hulbert SW, et al. Autism-associated CHD8 deficiency impairs axon improvement and migration of cortical neurons. Mol Autism. 2018;9:65.
Alotaibi M, Ramzan Ok. A de novo variant of CHD8 in a affected person with autism spectrum dysfunction. Discoveries (Craiova). 2020;8:e107–7.
Steadman PE, Ellegood J, Szulc KU, Turnbull DH, Joyner AL, Henkelman RM, et al. Genetic results on cerebellar construction throughout mouse fashions of autism utilizing a magnetic resonance imaging atlas. Autism Res: Off J Int Soc Autism Res. 2014;7:124–37.
Wen Z, Cheng T-L, Li G-Z, Sun S-B, Yu S-Y, Zhang Y, et al. Identification of autism-related MECP2 mutations by whole-exome sequencing and practical validation. Mol Autism. 2017;8:43.
Schoen M, Asoglu H, Bauer HF, Müller HP, Abaei A, Sauer AK, et al. Shank3 transgenic and prenatal zinc-deficient autism mouse fashions present convergent and particular person alterations of mind buildings in MRI. Front Neural Circuits. 2019;13:6.
Pagani M, Bertero A, Liska A, Galbusera A, Sabbioni M, Barsotti N, et al. Deletion of autism danger gene Shank3 disrupts prefrontal connectivity. J Neurosci. 2019;39:5299.
Lam M, Moslem M, Bryois J, Pronk RJ, Uhlin E, Ellström ID, et al. Single cell evaluation of autism affected person with bi-allelic NRXN1-alpha deletion reveals skewed destiny selection in neural progenitors and impaired neuronal performance. Exp Cell Res. 2019;383:111469.
Pervolaraki E, Tyson AL, Pibiri F, Poulter SL, Reichelt AC, Rodgers RJ, et al. The within-subject utility of diffusion tensor MRI and CLARITY reveals mind structural modifications in Nrxn2 deletion mice. Mol Autism. 2019;10:8.
Liska A, Bertero A, Gomolka R, Sabbioni M, Galbusera A, Barsotti N, et al. Homozygous lack of autism-risk gene CNTNAP2 ends in decreased native and long-range prefrontal practical connectivity. Cereb Cortex. 2018;28:1141–53.
de Jong JO, Llapashtica C, Genestine M, Strauss Ok, Provenzano F, Sun Y, et al. Cortical overgrowth in a preclinical forebrain organoid mannequin of CNTNAP2-associated autism spectrum dysfunction. Nat Commun. 2021;12:4087.
Jin D, Liu H-X, Hirai H, Torashima T, Nagai T, Lopatina O, et al. CD38 is vital for social behaviour by regulating oxytocin secretion. Nature. 2007;446:41–5.
Higashida H, Yokoyama S, Huang JJ, Liu L, Ma WJ, Akther S, et al. Social reminiscence, amnesia, and autism: mind oxytocin secretion is regulated by NAD+ metabolites and single nucleotide polymorphisms of CD38. Neurochem Int. 2012;61:828–38.
LoParo D, Waldman ID. The oxytocin receptor gene (OXTR) is related to autism spectrum dysfunction: a meta-analysis. Mol Psychiatry. 2015;20:640–6.
Uzefovsky F, Bethlehem RAI, Shamay-Tsoory S, Ruigrok A, Holt R, Spencer M, et al. The oxytocin receptor gene predicts mind exercise throughout an emotion recognition process in autism. Mol Autism. 2019;10:12.
de Oliveira Pereira Ribeiro L, Vargas-Pinilla P, Kappel DB, Longo D, Ranzan J, Becker MM, et al. Evidence for affiliation between OXTR gene and ASD scientific phenotypes. J Mol Neurosci. 2018;65:213–21.
Hernandez LM, Lawrence KE, Padgaonkar NT, Inada M, Hoekstra JN, Lowe JK, et al. Imaging-genetics of intercourse variations in ASD: distinct results of OXTR variants on mind connectivity. Transl Psychiatry. 2020;10:82.
Meyer-Lindenberg A, Kolachana B, Gold B, Olsh A, Nicodemus KK, Mattay V, et al. Genetic variants in AVPR1A linked to autism predict amygdala activation and persona traits in wholesome people. Mol Psychiatry. 2009;14:968–75.
Zhang Y, Zhu D, Zhang P, Li W, Qin W, Liu F, et al. Neural mechanisms of AVPR1A RS3-RS1 haplotypes that influence verbal studying and reminiscence. Neuroimage. 2020;222:117283.
Yang SY, Kim SA, Hur GM, Park M, Park J-E, Yoo HJ. Replicative genetic affiliation examine between practical polymorphisms in AVPR1A and social habits scales of autism spectrum dysfunction within the Korean inhabitants. Mol Autism. 2017;8:44.
Bosch C, Muhaisen A, Pujadas L, Soriano E, Martínez A. Reelin exerts structural, biochemical and transcriptional regulation over presynaptic and postsynaptic components within the grownup hippocampus. Front Cell Neurosci. 2016;10:138–8.
Fatemi SH. The function of Reelin in pathology of autism. Mol Psychiatry. 2002;7:919–20.
Lammert DB, Howell BW. RELN mutations in autism spectrum dysfunction. Front Cell Neurosci. 2016;10:84.
Lammert DB, Middleton FA, Pan J, Olson EC, Howell BW. The de novo autism spectrum dysfunction RELN R2290C mutation reduces Reelin secretion and will increase protein disulfide isomerase expression. J Neurochem. 2017;142:89–102.
Cuchillo-Ibáñez I, Andreo-Lillo P, Pastor-Ferrándiz L, Carratalá-Marco F, Sáez-Valero J. Elevated plasma reelin ranges in youngsters with autism. Front Psychiatry. 2020;11:242.
Huang T-N, Yen T-L, Qiu LR, Chuang H-C, Lerch JP, Hsueh Y-P. Haploinsufficiency of autism causative gene Tbr1 impairs olfactory discrimination and neuronal activation of the olfactory system in mice. Mol Autism. 2019;10:5.
Huang TN, Chuang HC, Chou WH, Chen CY, Wang HF, Chou SJ, et al. Tbr1 haploinsufficiency impairs amygdalar axonal projections and ends in cognitive abnormality. Nat Neurosci. 2014;17:240–7.
Sapey-Triomphe L-A, Reversat J, Lesca G, Chatron N, Bussa M, Mazoyer S, et al. A de novo frameshift pathogenic variant in TBR1 recognized in autism with out mental incapacity. Hum Genomics. 2020;14:32–32.
Yook C, Kim Ok, Kim D, Kang H, Kim S-G, Kim E, et al. A TBR1-K228E mutation induces Tbr1 upregulation, altered cortical distribution of interneurons, elevated inhibitory synaptic transmission, and autistic-like behavioral deficits in mice. Front Mol Neurosci. 2019;12:241.
Deriziotis P, O’Roak BJ, Graham SA, Estruch SB, Dimitropoulou D, Bernier RA, et al. De novo TBR1 mutations in sporadic autism disrupt protein features. Nat Commun. 2014;5:4954–4.
Yang R, Walder-Christensen Kathryn Ok, Kim N, Wu D, Lorenzo Damaris N, Badea A, et al. ANK2 autism mutation concentrating on large ankyrin-B promotes axon branching and ectopic connectivity. Proc Natl Acad Sci. 2019;116:15262–71.
Kawano S, Baba M, Fukushima H, Miura D, Hashimoto H, Nakazawa T. Autism-associated ANK2 regulates embryonic neurodevelopment. Biochem Biophys Res Commun. 2022;605:45–50.
Lai ESK, Nakayama H, Miyazaki T, Nakazawa T, Tabuchi Ok, Hashimoto Ok, et al. An autism-associated neuroligin-3 mutation impacts developmental synapse elimination within the cerebellum. Front Neural Circuits. 2021;15:676891.
Burrows EL, Laskaris L, Koyama L, Churilov L, Bornstein JC, Hill-Yardin EL, et al. A neuroligin-3 mutation implicated in autism causes irregular aggression and will increase repetitive habits in mice. Mol Autism. 2015;6:62.
Kumar M, Duda JT, Hwang W-T, Kenworthy C, Ittyerah R, Pickup S, et al. High decision magnetic resonance imaging for characterization of the neuroligin-3 knock-in mouse mannequin related to autism spectrum dysfunction. PLOS ONE. 2014;9:e109872.
Watts ME, Pocock R, Claudianos C. Brain vitality and oxygen metabolism: rising function in regular operate and illness. Front Mol Neurosci. 2018;11:216.
Lopes Cardoso I, Almeida S. Genes concerned within the improvement of autism. Int Arch Commun Disord. 2019;2:011.
Kurochkin I, Khrameeva E, Tkachev A, Stepanova V, Vanyushkina A, Stekolshchikova E, et al. Metabolome signature of autism within the human prefrontal cortex. Commun Biol. 2019;2:234.
Elia J, Glessner JT, Wang Ok, Takahashi N, Shtir CJ, Hadley D, et al. Genome-wide copy quantity variation examine associates metabotropic glutamate receptor gene networks with consideration deficit hyperactivity dysfunction. Nat Genet. 2011;44:78–84.
Lal D, Pernhorst Ok, Klein KM, Reif P, Tozzi R, Toliat MR, et al. Extending the phenotypic spectrum of RBFOX1 deletions: Sporadic focal epilepsy. Epilepsia. 2015;56:e129–133.
Griswold AJ, Dueker ND, Van Booven D, Rantus JA, Jaworski JM, Slifer SH, et al. Targeted massively parallel sequencing of autism spectrum disorder-associated genes in a case management cohort reveals uncommon loss-of-function danger variants. Mol Autism. 2015;6:43.
Xu B, Roos JL, Levy S, van Rensburg EJ, Gogos JA, Karayiorgou M. Strong affiliation of de novo copy quantity mutations with sporadic schizophrenia. Nat Genet. 2008;40:880–5.
Lee JA, Damianov A, Lin CH, Fontes M, Parikshak NN, Anderson ES, et al. Cytoplasmic Rbfox1 regulates the expression of synaptic and autism-related genes. Neuron. 2016;89:113–28.
Frye RE. Mitochondrial dysfunction in autism spectrum dysfunction: distinctive abnormalities and focused therapies. Semin Pediatr Neurol. 2020;35:100829.
Boenzi S, Diodato D. Biomarkers for mitochondrial vitality metabolism ailments. Essays Biochem. 2018;62:443–54.
Khemakhem AM, Frye RE, El-Ansary A, Al-Ayadhi L, Bacha AB. Novel biomarkers of metabolic dysfunction is autism spectrum dysfunction: potential for organic diagnostic markers. Metab Brain Dis. 2017;32:1983–97.
Correia C, Coutinho AM, Diogo L, Grazina M, Marques C, Miguel T, et al. Brief report: High frequency of biochemical markers for mitochondrial dysfunction in autism: no affiliation with the mitochondrial aspartate/glutamate service SLC25A12 gene. J Autism Dev Disord. 2006;36:1137–40.
Ramirez-Celis A, Edmiston E, Schauer J, Vu T, Van de Water J. Peptides of neuron particular enolase as potential ASD biomarkers: from discovery to epitope mapping. Brain Behav Immun. 2020;84:200–8.
Ramirez-Celis A, Becker M, Nuño M, Schauer J, Aghaeepour N, Van de Water J. Risk evaluation evaluation for maternal autoantibody-related autism (MAR-ASD): a subtype of autism. Mol Psychiatry. 2021;26:1551–60.
Braunschweig D, Krakowiak P, Duncanson P, Boyce R, Hansen RL, Ashwood P, et al. Autism-specific maternal autoantibodies acknowledge vital proteins in growing mind. Transl Psychiatry. 2013;3:e277–7.
Mergenthaler P, Lindauer U, Dienel GA, Meisel A. Sugar for the mind: the function of glucose in physiological and pathological mind operate. Trends Neurosci. 2013;36:587–97.
Vannucci SJ. Developmental expression of GLUT1 and GLUT3 glucose transporters in rat mind. J Neurochem. 1994;62:240–6.
Zhou J, Burns MP, Huynh L, Villapol S, Taub DD, Saavedra JM, et al. Temporal modifications in cortical and hippocampal expression of genes vital for mind glucose metabolism following managed cortical influence harm in mice. Front Endocrinol. 2017;8:231.
Zhao Y, Fung C, Shin D, Shin BC, Thamotharan S, Sankar R, et al. Neuronal glucose transporter isoform 3 poor mice display options of autism spectrum issues. Mol Psychiatry. 2010;15:286–99.
Liu M, Chen Y, Sun M, Du Y, Bai Y, Lei G, et al. Auts2 regulated autism-like habits, glucose metabolism and oxidative stress in mice. Exp Neurol. 2022;361:114298.
Orth M, Bellosta S. Cholesterol: its regulation and function in central nervous system issues. Cholesterol. 2012;2012:292598.
Pikuleva IA, Cartier N. Cholesterol hydroxylating cytochrome P450 46A1: from mechanisms of motion to scientific functions. Front Aging Neurosci. 2021;13:696778.
Grayaa S, Zerbinati C, Messedi M, HadjKacem I, Chtourou M, Ben Touhemi D, et al. Plasma oxysterol profiling in youngsters reveals 24-hydroxycholesterol as a possible marker for Autism Spectrum Disorders. Biochimie. 2018;153:80–5.
Bradshaw NJ, Porteous DJ. DISC1-binding proteins in neural improvement, signalling and schizophrenia. Neuropharmacology. 2012;62:1230–41.
Deng D, Jian C, Lei L, Zhou Y, McSweeney C, Dong F, et al. A prenatal interruption of DISC1 operate within the mind reveals an enduring influence on grownup behaviors, mind metabolism, and interneuron improvement. Oncotarget. 2017;8:84798–817.
Jouroukhin Y, Kageyama Y, Misheneva V, Shevelkin A, Andrabi S, Prandovszky E, et al. DISC1 regulates lactate metabolism in astrocytes: implications for psychiatric issues. Transl Psychiatry. 2018;8:76–6.
Wentz E, Björk A, Dahlgren J. Neurodevelopmental issues are extremely over-represented in youngsters with weight problems: a cross-sectional examine. Obes (Silver Spring). 2017;25:178–84.
Köse S, Yılmaz Kafalı H, Erkan İdris ZG, Şentürk Pilan B, Özbaran B, Erermiş S. The prevalence and danger components for obese/weight problems amongst Turkish youngsters with neurodevelopmental issues. Res Develop Disab. 2021;114:103992
Labouesse MA, Lassalle O, Richetto J, Iafrati J, Weber-Stadlbauer U, Notter T, et al. Hypervulnerability of the adolescent prefrontal cortex to dietary stress by way of reelin deficiency. Mol Psychiatry. 2017;22:961–71.
Lane-Donovan C, Herz J. The ApoE receptors Vldlr and Apoer2 in central nervous system operate and illness: thematic evaluate collection: ApoE and lipid homeostasis in Alzheimer’s Disease. J Lipid Res. 2017;58:1036–43.
Roberts BL, Bennett BJ, Bennett CM, Carroll JM, Dalbøge LS, Hall C, et al. Reelin is modulated by diet-induced weight problems and has direct actions on arcuate proopiomelanocortin neurons. Mol Metab. 2019;26:18–29.
Uchino S, Waga C. SHANK3 as an autism spectrum disorder-associated gene. Brain Dev. 2013;35:106–10.
Torossian A, Saré RM, Loutaev I, Smith CB. Increased charges of cerebral protein synthesis in Shank3 knockout mice: Implications for a hyperlink between synaptic protein deficit and dysregulated protein synthesis in autism spectrum dysfunction/mental incapacity. Neurobiol Dis. 2021;148:105213.
Anil Kumar BN, Malhotra S, Bhattacharya A, Grover S, Batra YK. Regional cerebral glucose metabolism and its affiliation with phenotype and cognitive functioning in sufferers with autism. Indian J Psychol Med. 2017;39:262–70.
Thomas RH, Foley KA, Mepham JR, Tichenoff LJ, Possmayer F, MacFabe DF. Altered mind phospholipid and acylcarnitine profiles in propionic acid infused rodents: additional improvement of a possible mannequin of autism spectrum issues. J Neurochem. 2010;113:515–29.
Rumsey JM, Duara R, Grady C, Rapoport JL, Margolin RA, Rapoport SI, et al. Brain metabolism in autism: resting cerebral glucose utilization charges as measured with positron emission tomography. Arch Gen Psychiatry. 1985;42:448–55.
Oh M, Kim SA, Yoo HJ. Higher lactate stage and lactate-to-pyruvate ratio in autism spectrum dysfunction. Exp Neurobiol. 2020;29:314–22.
Di Gialleonardo V, Wilson DM, Keshari KR. The potential of metabolic imaging. Semin Nucl Med. 2016;46:28–39.
Żarnowska I, Chrapko B, Gwizda G, Nocuń A, Mitosek-Szewczyk Ok, Gasior M. Therapeutic use of carbohydrate-restricted diets in an autistic little one; a case report of scientific and 18FDG PET findings. Metab Brain Dis. 2018;33:1187–92.
Leblanc H. Brain abnormality findings in F18-FDG PET/CT imaging and its function within the scientific analysis of autism. J Nucl Med. 2017;58:828.
Chivate R, Thakrar P, Narang J, Kumar S, Verma M, Patkar D. et al. PET/CT in Autism, A Diagnostic instrument. Int J Health Sci Res. 2016;6:99–106.
Manglunia AS, Puranik AD. FDG PET/CT findings in a clinically identified case of childhood autism. Indian J Nucl Med. 2016;31:138–40.
Ajram LA, Pereira AC, Durieux AMS, Velthius HE, Petrinovic MM, McAlonan GM. The contribution of [1H] magnetic resonance spectroscopy to the examine of excitation-inhibition in autism. Prog Neuro-Psychopharmacol Biol Psychiatry. 2019;89:236–44.
Hyder F, Rothman DL. Advances in imaging mind metabolism. Annu Rev Biomed Eng. 2017;19:485–515.
Minshew NJ, Goldstein G, Dombrowski SM, Panchalingam Ok, Pettegrew JW. A preliminary 31P MRS examine of autism: proof for undersynthesis and elevated degradation of mind membranes. Biol Psychiatry. 1993;33:762–73.
Golomb BA, Erickson LC, Zeeland AAS-V, Koperski S, Haas RH, Wallace DC, et al. Assessing bioenergetic compromise in autism spectrum dysfunction with 31P magnetic resonance spectroscopy: preliminary report. J Child Neurol. 2013;29:187–93.
El-Ansary A, Qasem H. Correction of fatty acids metabolism as remedy technique of autism. In: Angel C Editor. InTech. 2017.
Muir D, Berl S, Clarke DD. Acetate and fluoroacetate as attainable markers for glial metabolism in vivo. Brain Res. 1986;380:336–40.
Wyss MT, Magistretti PJ, Buck A, Weber B. Labeled acetate as a marker of astrocytic metabolism. J Cereb Blood Flow Metab. 2011;31:1668–74.
Deford-Watts LM, Mintz A, Kridel SJ. The potential of 11C-acetate PET for monitoring the Fatty acid synthesis pathway in Tumors. Curr Pharm Biotechnol. 2013;14:300–12.
Kato H, Okuno T, Isohashi Ok, Koda T, Shimizu M, Mochizuki H, et al. Astrocyte metabolism in a number of sclerosis investigated by 1-C-11 acetate PET. J Cereb Blood Flow Metab. 2020;41:369–79.
Takata Ok, Kato H, Shimosegawa E, Okuno T, Koda T, Sugimoto T, et al. 11C-acetate PET imaging in sufferers with a number of sclerosis. PloS One. 2014;9:e111598–98.
Duong MT, Chen YJ, Doot RK, Young AJ, Lee H, Cai J, et al. Astrocyte activation imaging with 11C-acetate and amyloid PET in delicate cognitive impairment as a consequence of Alzheimer pathology. Nucl Med Commun. 2021;42:1261–9.
Çetin F, Tunca H, Guney E, Iseri E. Neurotransmitter methods in autism spectrum dysfunction. In: Michael F Editor. InTech. 2015, pp 15–30.
Muller CL, Anacker AMJ, Veenstra-VanderWeele J. The serotonin system in autism spectrum dysfunction: from biomarker to animal fashions. Neuroscience. 2016;321:24–41.
Kosillo P, Bateup HS. Dopaminergic dysregulation in syndromic autism spectrum issues: insights from genetic mouse fashions. Front Neural Circuits. 2021;15:700968–68.
Montanari M, Martella G, Bonsi P, Meringolo M. Autism spectrum dysfunction: give attention to glutamatergic neurotransmission. Int J Mol Sci. 2022;23:3861.
Zhao H, Mao X, Zhu C, Zou X, Peng F, Yang W, et al. GABAergic system dysfunction in autism spectrum issues. Front Cell Dev Biol. 2022;9:781327.
Cools R. Role of dopamine within the motivational and cognitive management of habits. Neuroscientist. 2008;14:381–95.
DiCarlo GE, Aguilar JI, Matthies HJ, Harrison FE, Bundschuh KE, West A, et al. Autism-linked dopamine transporter mutation alters striatal dopamine neurotransmission and dopamine-dependent behaviors. J Clin Invest. 2019;129:3407–19.
Hettinger JA, Liu X, Hudson ML, Lee A, Cohen IL, Michaelis RC, et al. DRD2 and PPP1R1B (DARPP-32) polymorphisms independently confer elevated danger for autism spectrum issues and additively predict affected standing in male-only affected sib-pair households. Behav Brain Funct. 2012; 8:19–9.
Hamilton PJ, Campbell NG, Sharma S, Erreger Ok, Herborg Hansen F, Saunders C, et al. De novo mutation within the dopamine transporter gene associates dopamine dysfunction with autism spectrum dysfunction. Mol Psychiatry. 2013;18:1315–23.
Dierckx RAJO, Otte A, de Vries EFJ, van Waarde A, Leenders KL. PET and SPECT in Neurology. Springer International Publishing 2020.
Schalbroeck R, van Velden FHP, de Geus-Oei L-F, Yaqub M, van Amelsvoort T, Booij J, et al. Striatal dopamine synthesis capability in autism spectrum dysfunction and its relation with social defeat: an [(18)F]-FDOPA PET/CT examine. Transl Psychiatry. 2021;11:47–7.
Schalbroeck R, de Geus-Oei LF, Selten JP, Yaqub M, Schrantee A, van Amelsvoort T, et al. Cerebral [(18)F]-FDOPA uptake in autism spectrum dysfunction and its affiliation with autistic traits. Diagnostics (Basel). 2021;11:2404.
Nakamura Ok, Sekine Y, Ouchi Y, Tsujii M, Yoshikawa E, Futatsubashi M, et al. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry. 2010;67:59–68.
Zürcher NR, Walsh EC, Phillips RD, Cernasov PM, Tseng C-EJ, Dharanikota A, et al. A simultaneous [11C]raclopride positron emission tomography and practical magnetic resonance imaging investigation of striatal dopamine binding in autism. Transl Psychiatry. 2021;11:33.
Fernell E, Watanabe Y, Adolfsson I, Tani Y, Bergström M, Hartvig P, et al. Possible results of tetrahydrobiopterin remedy in six youngsters with autism-clinical and positron emission tomography knowledge: a pilot examine. Dev Med Child Neurol. 1997;39:313–8.
Kubota M, Fujino J, Tei S, Takahata Ok, Matsuoka Ok, Tagai Ok, et al. Binding of Dopamine D1 receptor and noradrenaline transporter in people with autism spectrum dysfunction: a PET examine. Cereb Cortex. 2020;30:6458–68.
Yang CJ, Tan HP, Du YJ. The developmental disruptions of serotonin signaling might concerned in autism throughout early mind improvement. Neuroscience. 2014;267:1–10.
Adamsen D, Ramaekers V, Ho HT, Britschgi C, Rüfenacht V, Meili D, et al. Autism spectrum dysfunction related to low serotonin in CSF and mutations within the SLC29A4 plasma membrane monoamine transporter (PMAT) gene. Mol Autism. 2014;5:43.
Sjaarda CP, Hecht P, McNaughton AJM, Zhou A, Hudson ML, Will MJ, et al. Interplay between maternal Slc6a4 mutation and prenatal stress: a attainable mechanism for autistic habits improvement. Sci Rep. 2017;7:8735.
Coutinho AM, Oliveira G, Morgadinho T, Fesel C, Macedo TR, Bento C, et al. Variants of the serotonin transporter gene (SLC6A4) considerably contribute to hyperserotonemia in autism. Mol Psychiatry. 2004;9:264–71.
Wongpaiboonwattana W, Plong-On O, Hnoonual A, Limprasert P. Significant associations between 5-hydroxytryptaminetransporter-linked promoter area polymorphisms of the serotonin transporter (solute service household 6 member 4) gene and Thai sufferers with autism spectrum dysfunction. Medicine. 2020;99:e21946.
Coutinho AM, Sousa I, Martins M, Correia C, Morgadinho T, Bento C, et al. Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and within the dedication of platelet serotonin ranges. Hum Genet. 2007;121:243–56.
Roth W, Zadeh Ok, Vekariya R, Ge Y, Mohamadzadeh M. Tryptophan metabolism and gut-brain homeostasis. Int J Mol Sci. 2021;22:2973.
Nourbakhsh B, Bhargava P, Tremlett H, Hart J, Graves J, Waubant E. Altered tryptophan metabolism is related to pediatric a number of sclerosis danger and course. Ann Clin Transl Neurol. 2018;5:1211–21.
Sorgdrager F, van Der Ley CP, van Faassen M, Calus E, Nollen EA, Kema IP, et al. The impact of tryptophan 2,3-dioxygenase inhibition on kynurenine metabolism and cognitive operate within the APP23 mouse mannequin of Alzheimer’s Disease. Int J Tryptophan Res. 2020;13:1178646920972657–2657.
Chiappelli J, Postolache TT, Kochunov P, Rowland LM, Wijtenburg SA, Shukla DK, et al. Tryptophan metabolism and white matter integrity in schizophrenia. Neuropsychopharmacology. 2016;41:2587–95.
Szabó N, Kincses ZT, Toldi J, Vécsei L. Altered tryptophan metabolism in Parkinson’s illness: a attainable novel therapeutic method. J Neurol Sci. 2011;310:256–60.
Boccuto L, Chen C-F, Pittman AR, Skinner CD, McCartney HJ, Jones Ok, et al. Decreased tryptophan metabolism in sufferers with autism spectrum issues. Mol Autism. 2013;4:16–16.
Asano E, Chugani DC, Muzik O, Behen M, Janisse J, Rothermel R, et al. Autism in tuberous sclerosis complicated is expounded to each cortical and subcortical dysfunction. Neurology. 2001;57:1269–77.
De Felice LJ. A present view of serotonin transporters. F1000Res. 2016;5:F1000 Faculty Rev-1884.
Cook EH Jr, Courchesne R, Lord C, Cox NJ, Yan S, Lincoln A, et al. Evidence of linkage between the serotonin transporter and autistic dysfunction. Mol Psychiatry. 1997;2:247–50.
Prasad HC, Steiner JA, Sutcliffe JS, Blakely RD. Enhanced exercise of human serotonin transporter variants related to autism. Philos Trans R Soc Lond B Biol Sci. 2009;364:163–73.
Xie M-J, Iwata Ok, Ishikawa Y, Nomura Y, Tani T, Murata Ok, et al. Autistic-like habits and impairment of serotonin transporter and AMPA receptor trafficking in N-ethylmaleimide delicate issue gene-deficient mice. Front Genet. 2021;12:748627.
Guo CC-G, Minda JP, Homberg J. Serotonin transporter knockout in rats modulates class studying. bioRxiv. 2020: https://doi.org/10.1101/2020.11.09.373886.
Wilson AA, Ginovart N, Hussey D, Meyer J, Houle S. In vitro and in vivo characterisation of [11C]-DASB: a probe for in vivo measurements of the serotonin transporter by positron emission tomography. Nucl Med Biol. 2002;29:509–15.
Girgis RR, Slifstein M, Xu X, Frankle WG, Anagnostou E, Wasserman S, et al. The 5-HT(2A) receptor and serotonin transporter in Asperger’s dysfunction: a PET examine with [11C]MDL 100907 and [11C]DASB. Psychiatry Res. 2011;194:230–4.
Andersson M, Tangen Ä, Farde L, Bölte S, Halldin C, Borg J, et al. Serotonin transporter availability in adults with autism—a positron emission tomography examine. Mol Psychiatry. 2021;26:1647–58.
Lundberg J, Halldin C, Farde L. Measurement of serotonin transporter binding with PET and [11C]MADAM: a test-retest reproducibility examine. Synapse. 2006;60:256–63.
Suehiro M, Scheffel U, Ravert HT, Dannals RF, Wagner HN Jr. [11C](+)McN5652 as a radiotracer for imaging serotonin uptake websites with PET. Life Sci. 1993;53:883–92.
Saitow F, Takumi T, Suzuki H. Upregulated 5-HT1A receptor-mediated currents within the prefrontal cortex layer 5 neurons within the 15q11–13 duplication mouse mannequin of autism. Mol Brain. 2020;13:115.
Abdelrahman HM, Sherief LM, Alghobashy AA, Abdel Salam SM, Hashim HM, Abdel Fattah NR, et al. Association of 5-HT2A receptor gene polymorphisms with gastrointestinal issues in Egyptian youngsters with autistic dysfunction. Res Develop Disabil. 2015;36:485–90.
Fan C, Gao Y, Liang G, Huang L, Wang J, Yang X, et al. Transcriptomics of Gabra4 knockout mice reveals frequent NMDAR pathways underlying autism, reminiscence, and epilepsy. Mol Autism. 2020;11:13.
Chen C-H, Huang C-C, Cheng M-C, Chiu Y-N, Tsai W-C, Wu Y-Y, et al. Genetic evaluation of GABRB3 as a candidate gene of autism spectrum issues. Mol Autism. 2014;5:36.
Cook EH Jr, Courchesne RY, Cox NJ, Lord C, Gonen D, Guter SJ, et al. Linkage-disequilibrium mapping of autistic dysfunction, with 15q11-13 markers. Am J Hum Genet. 1998;62:1077–83.
Fung LK, Flores RE, Gu M, Sun KL, James D, Schuck RK, et al. Thalamic and prefrontal GABA concentrations however not GABA(A) receptor densities are altered in high-functioning adults with autism spectrum dysfunction. Mol Psychiatry. 2021;26:1634–46.
Horder J, Andersson M, Mendez MA, Singh N, Tangen Ä, Lundberg J, et al. GABA(A) receptor availability is just not altered in adults with autism spectrum dysfunction or in mouse fashions. Sci Transl Med. 2018;10:eaam8434.
Mendez MA, Horder J, Myers J, Coghlan S, Stokes P, Erritzoe D, et al. The mind GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum dysfunction: a pilot [(11)C]Ro15-4513 positron emission tomography examine. Neuropharmacology. 2013;68:195–201.
Safavynia SA, Keating G, Speigel I, Fidler JA, Kreuzer M, Rye DB, et al. Effects of γ-aminobutyric acid sort A receptor modulation by flumazenil on emergence from normal anesthesia. Anesthesiology. 2016;125:147–58.
The Role of Glutamate within the Healthy Brain and within the Pathophysiology of Parkinson’s Disease. European Neurological Review. 2019;14(Suppl.2):2–12.
Nisar S, Bhat AA, Masoodi T, Hashem S, Akhtar S, Ali TA, et al. Genetics of glutamate and its receptors in autism spectrum dysfunction. Mol Psychiatry. 2022;27:2380–92.
Wong DF, Waterhouse R, Kuwabara H, Kim J, Brašić JR, Chamroonrat W, et al. 18F-FPEB, a PET radiopharmaceutical for quantifying metabotropic glutamate 5 receptors: a first-in-human examine of radiochemical security, biokinetics, and radiation dosimetry. J Nucl Med. 2013;54:388–96.
Toyohara J, Sakata M, Oda Ok, Ishii Ok, Ito Ok, Hiura M, et al. Initial human PET research of metabotropic glutamate receptor sort 1 ligand 11C-ITMM. J Nucl Med. 2013;54:1302–7.
Yamasaki T, Kumata Ok, Yui J, Fujinaga M, Furutsuka Ok, Hatori A, et al. Synthesis and analysis of [11C]MMPIP as a possible radioligand for imaging of metabotropic glutamate 7 receptor within the mind. EJNMMI Res. 2013;3:54.
Cai G, Wang M, Wang S, Liu Y, Zhao Y, Zhu Y, et al. Brain mGluR5 in Shank3B(−/−) mice studied with in vivo [(18)F]FPEB PET imaging and ex vivo immunoblotting. Front Psychiatry. 2019;10:38–8.
Fatemi SH, Wong DF, Brašić JR, Kuwabara H, Mathur A, Folsom TD, et al. Metabotropic glutamate receptor 5 tracer [(18)F]-FPEB shows elevated binding potential in postcentral gyrus and cerebellum of male people with autism: a pilot PET examine. Cerebellum Ataxias. 2018;5:3.
Brašić JR, Nandi A, Russell DS, Jennings D, Barret O, Martin SD, et al. Cerebral expression of metabotropic glutamate receptor subtype 5 in idiopathic autism spectrum dysfunction and fragile X syndrome: a pilot examine. Int J Mol Sci. 2021;22:2863.
Lefevre A, Richard N, Mottolese R, Leboyer M, Sirigu A. An affiliation between serotonin 1A receptor, grey matter quantity, and sociability in wholesome topics and in autism spectrum dysfunction. Autism Res. 2020;13:1843–55.
Beversdorf DQ, Nordgren RE, Bonab AA, Fischman AJ, Weise SB, Dougherty DD, et al. 5-HT2 receptor distribution proven by [18F] setoperone PET in high-functioning autistic adults. J Neuropsychiatry Clin Neurosci. 2012;24:191–7.
Goldberg J, Anderson GM, Zwaigenbaum L, Hall GB, Nahmias C, Thompson A, et al. Cortical serotonin type-2 receptor density in dad and mom of kids with autism spectrum issues. J Autism Dev Disord. 2009;39:97–104.
Park G, Jeon SJ, Ko IO, Park JH, Lee KC, Kim M-S, et al. Decreased in vivo glutamate/GABA ratio correlates with the social habits deficit in a mouse mannequin of autism spectrum dysfunction. Mol Brain. 2022;15:19.
Zieminska E, Toczylowska B, Diamandakis D, Hilgier W, Filipkowski RK, Polowy R, et al. Glutamate, glutamine and GABA ranges in rat mind measured utilizing MRS, HPLC and NMR strategies in examine of two fashions of autism. Front Mol Neurosci. 2018;11:418.
Luchicchi A, Bloem B, Viaña JNM, Mansvelder HD, Role LW. Illuminating the function of cholinergic signaling in circuits of consideration and emotionally salient behaviors. Front Synaptic Neurosci. 2014;6:24.
Picciotto MR, Higley MJ, Mineur YS. Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system operate and habits. Neuron. 2012;76:116–29.
Mikhail FM, Lose EJ, Robin NH, Descartes MD, Rutledge KD, Rutledge SL, et al. Clinically related single gene or intragenic deletions encompassing vital neurodevelopmental genes in sufferers with developmental delay, psychological retardation, and/or autism spectrum issues. Am J Med Genet A. 2011;155a:2386–96.
Leblond CS, Heinrich J, Delorme R, Proepper C, Betancur C, Huguet G, et al. Genetic and practical analyses of SHANK2 mutations counsel a a number of hit mannequin of autism spectrum issues. PLoS Genet. 2012;8:e1002521.
Suzuki Ok, Sugihara G, Ouchi Y, Nakamura Ok, Tsujii M, Futatsubashi M, et al. Reduced acetylcholinesterase exercise within the fusiform gyrus in adults with autism spectrum issues. Arch Gen Psychiatry. 2011;68:306–13.
Drenthen GS, Barendse EM, Aldenkamp AP, van Veenendaal TM, Puts NAJ, Edden RAE, et al. Altered neurotransmitter metabolism in adolescents with high-functioning autism. Psychiatry Res Neuroimaging. 2016;256:44–9.
Cai Ok, Haris M, Singh A, Kogan F, Greenberg JH, Hariharan H, et al. Magnetic resonance imaging of glutamate. Nat Med. 2012;18:302–6.
Bagga P, Pickup S, Crescenzi R, Martinez D, Borthakur A, D’Aquilla Ok, et al. In vivo GluCEST MRI: reproducibility, background contribution and supply of glutamate modifications within the MPTP mannequin of Parkinson’s illness. Sci Rep. 2018;8:2883.
Kogan F, Hariharan H, Reddy R. Chemical trade saturation switch (CEST) imaging: description of approach and potential scientific functions. Curr Radio Rep. 2013;1:102–14.
Mao Y, Zhuang Z, Chen Y, Zhang X, Shen Y, Lin G, et al. Imaging of glutamate in acute traumatic mind harm utilizing chemical trade saturation switch. Quant Imaging Med Surg. 2019;9:1652–63.
Roalf DR, Nanga RPR, Rupert PE, Hariharan H, Quarmley M, Calkins ME, et al. Glutamate imaging (GluCEST) reveals decrease mind GluCEST distinction in sufferers on the psychosis spectrum. Mol Psychiatry. 2017;22:1298–305.
Haris M, Nath Ok, Cai Ok, Singh A, Crescenzi R, Kogan F, et al. Imaging of glutamate neurotransmitter alterations in Alzheimer’s illness. NMR Biomed. 2013;26:386–91.
Pépin J, de Longprez L, Trovero F, Brouillet E, Valette J, Flament J. Complementarity of gluCEST and (1) H-MRS for the examine of mouse fashions of Huntington’s illness. NMR Biomed. 2020;33:e4301.
Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, et al. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology. 2000;22:133–9.
Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, et al. Patterns of mind activation in individuals in danger for Alzheimer’s illness. N. Engl J Med. 2000;343:450–6.
Mufford MS, Stein DJ, Dalvie S, Groenewold NA, Thompson PM, Jahanshad N. Neuroimaging genomics in psychiatry-a translational method. Genome Med. 2017;9:102–2.
Voineskos AN, Lett TAP, Lerch JP, Tiwari AK, Ameis SH, Rajji TK, et al. Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum issues. PLOS ONE. 2011;6:e20982.
Whalley HC, O’Connell G, Sussmann JE, Peel A, Stanfield AC, Hayiou-Thomas ME, et al. Genetic variation in CNTNAP2 alters mind operate throughout linguistic processing in wholesome people. Am J Med Genet Part B: Neuropsychiatr Genet. 2011;156:941–8.
Zeeland A, Abrahams B, Alvarez-Retuerto A, Sonnenblick L, Rudie J, Ghahremani D, et al. Altered practical connectivity in frontal lobe circuits is related to variation within the autism danger gene CNTNAP2. Sci Transl Med. 2010;2:56ra80.
Sauer S, Ziegler M, Danay E, Ives J, Kohls N. Specific objectivity of mindfulness—a rasch evaluation of the freiburg mindfulness stock. Mindfulness. 2013;4:45–54.
Lintas C, Sacco R, Azzarà A, Cassano I, Gurrieri F. Genotype-phenotype correlations in relation to newly rising monogenic types of autism spectrum dysfunction and related neurodevelopmental issues: the significance of phenotype reevaluation after pangenomic outcomes. J Clin Med. 2021;10:5060.
Chaddad A, Li J, Lu Q, Li Y, Okuwobi IP, Tanougast C, et al. Can autism be identified with synthetic intelligence? A story evaluate. Diagnostics (Basel, Switz). 2021;11:2032.
Eslami T, Almuqhim F, Raiker JS, Saeed F. Machine studying strategies for diagnosing autism spectrum dysfunction and attention- deficit/hyperactivity dysfunction utilizing practical and structural MRI: a survey. Front Neuroinform. 2021;14:575999.
Dekhil O, Hajjdiab H, Shalaby A, Ali MT, Ayinde B, Switala A, et al. Using resting state practical MRI to build a personalised autism analysis system. PLoS One. 2018;13:e0206351.
Guo X, Dominick KC, Minai AA, Li H, Erickson CA, Lu LJ. Diagnosing autism spectrum dysfunction from mind resting-state practical connectivity patterns utilizing a deep neural community with a novel characteristic choice methodology. Front Neurosci. 2017;11:460.
Heinsfeld AS, Franco AR, Craddock RC, Buchweitz A, Meneguzzi F. Identification of autism spectrum dysfunction utilizing deep studying and the ABIDE dataset. Neuroimage Clin. 2017;17:16–23.
Li H, Parikh NA, He L. A novel switch studying method to boost deep neural community classification of mind practical connectomes. Front Neurosci. 2018;12:491.
Eslami T, Mirjalili V, Fong A, Laird AR, Saeed F. ASD-DiagNet: a hybrid studying method for detection of autism spectrum dysfunction utilizing fMRI knowledge. Front Neuroinform. 2019;13:70.
Eslami T, Saeed F. Auto-ASD-network: a method primarily based on deep studying and help vector machines for diagnosing autism spectrum dysfunction utilizing fMRI Data. Proceedings of the tenth ACM International Conference on Bioinformatics, Computational Biology and Health Informatics. Association for Computing Machinery: Niagara Falls, NY, USA, 2019, pp 646–51.
Wang C, Xiao Z, Wang B, Wu J. Identification of Autism primarily based on SVM-RFE and stacked sparse auto-encoder. IEEE Access. 2019;7:118030–6.
Ruan M, Webster PJ, Li X, Wang S. Deep neural community reveals the world of autism from a first-person perspective. Autism Res. 2021;14:333–42.
Sherkatghanad Z, Akhondzadeh M, Salari S, Zomorodi-Moghadam M, Abdar M, Acharya UR, et al. Automated detection of autism spectrum dysfunction utilizing a convolutional neural community. Front Neurosci. 2020;13:1325.
Khosla M, Jamison Ok, Kuceyeski A, Sabuncu MR. Ensemble studying with 3D convolutional neural networks for practical connectome-based prediction. Neuroimage. 2019;199:651–62.
Haweel R, Seada N, Ghoniemy S, Alghamdi NS, El-Baz AA. CNN deep native and international ASD classification method with steady wavelet rework utilizing task-based FMRI. Sens (Basel). 2021;21:5822.
Zou L, Zheng J, Miao C, Mckeown MJ, Wang ZJ. 3D CNN primarily based computerized analysis of consideration deficit hyperactivity dysfunction utilizing practical and structural MRI. IEEE Access. 2017;5:23626–36.
Guan J, Wang Y, Lin Y, Yin Q, Zhuang Y, Ji G. Cell type-specific predictive fashions carry out prioritization of genes and gene units related to autism. Front Genet. 2020;11:628539.
Albahri AS, Hamid RA, Zaidan AA, Albahri OS. Early automated prediction mannequin for the analysis and detection of kids with autism spectrum issues primarily based on efficient sociodemographic and household attribute options. Neural Comput Appl. 2023;35:921–47.
Rajendran DPD, Sundarraj RP. Using subject fashions with looking historical past in hybrid collaborative filtering recommender system: Experiments with consumer rankings. Int J Inf Manag Data Insights. 2021;1:100027.
Kohli M, Kar AK, Bangalore A, Ap P. Machine learning-based ABA remedy advice and personalization for autism spectrum dysfunction: an exploratory examine. Brain Inf. 2022;9:16.
Megerian JT, Dey S, Melmed RD, Coury DL, Lerner M, Nicholls CJ, et al. Evaluation of a man-made intelligence-based medical machine for analysis of autism spectrum dysfunction. npj Digital Med. 2022;5:57.
Mujeeb Rahman KK, Subashini MM. Identification of autism in youngsters utilizing static facial options and deep neural networks. Brain Sci. 2022;12:94.
Parlett-Pelleriti CM, Stevens E, Dixon D, Linstead EJ. Applications of unsupervised machine studying in autism spectrum dysfunction analysis: a evaluate. Rev J Autism Dev Disorders. 2022; https://doi.org/10.1007/s40489-021-00299-y.
Gardner-Hoag J, Novack M, Parlett-Pelleriti C, Stevens E, Dixon D, Linstead E. Unsupervised machine studying for figuring out difficult habits profiles to discover cluster-based remedy efficacy in youngsters with autism spectrum dysfunction: retrospective knowledge evaluation examine. JMIR Med Inf. 2021;9:e27793–93.
Usta MB, Karabekiroglu Ok, Sahin B, Aydin M, Bozkurt A, Karaosman T, et al. Use of machine studying strategies in prediction of short-term end result in autism spectrum issues. Psychiatry Clin Psychopharmacol. 2019;29:320–5.
Lin Y, Afshar S, Rajadhyaksha AM, Potash JB, Han S. A machine studying method to predicting autism danger genes: validation of identified genes and discovery of latest candidates. Front Genet. 2020;11:500064.
Wang H, Avillach P. Diagnostic classification and prognostic prediction utilizing frequent genetic variants in autism spectrum dysfunction: genotype-based deep studying. JMIR Med Inf. 2021;9:e24754.
Alzubi R, Ramzan N, Alzoubi H. Hybrid characteristic choice methodology for autism spectrum dysfunction SNPs. 2017 IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB), Manchester, UK. 2017, pp 1–7; https://doi.org/10.1109/CIBCB.2017.8058526.
Chen CP, Keown CL, Jahedi A, Nair A, Pflieger ME, Bailey BA, et al. Diagnostic classification of intrinsic practical connectivity highlights somatosensory, default mode, and visible areas in autism. Neuroimage Clin. 2015;8:238–45.
Wang M, Zhang D, Huang J, Yap PT, Shen D, Liu M. Identifying autism spectrum dysfunction with multi-site fMRI by way of low-rank area adaptation. IEEE Trans Med Imaging. 2020;39:644–55.
Price T, Wee CY, Gao W, Shen D. Multiple-network classification of childhood autism utilizing practical connectivity dynamics. Med Image Comput Comput Assist Inter. 2014;17:177–84.
Chen H, Duan X, Liu F, Lu F, Ma X, Zhang Y, et al. Multivariate classification of autism spectrum dysfunction utilizing frequency-specific resting-state practical connectivity—a multi-center examine. Prog Neuro-Psychopharmacol Biol Psychiatry. 2016;64:1–9.
Traut N, Heuer Ok, Lemaître G, Beggiato A, Germanaud D, Elmaleh M, et al. Insights from an autism imaging biomarker problem: guarantees and threats to biomarker discovery. Neuroimage. 2022;255:119171.
Katuwal GJ, Cahill ND, Baum SA, Michael AM. The predictive energy of structural MRI in Autism analysis. Annu Int Conf IEEE Eng Med Biol Soc. 2015;2015:4270–3.
Duchesnay E, Cachia A, Boddaert N, Chabane N, Mangin J-F, Martinot J-L, et al. Feature choice and classification of imbalanced datasets: utility to PET pictures of kids with autistic spectrum issues. Neuroimage. 2011;57:1003–14.
Koumakis L. Deep studying fashions in genomics; are we there but? Comput Struct Biotechnol J. 2020;18:1466–73.
